Share market update: Pharma shares fall; Piramal Enterprises slumps 8%

Share market update: Pharma shares fall; Piramal Enterprises slumps 8%

NEW DELHI: Most pharma shares were under pressure with the Nifty Pharma index trading 0.64 per cent down at 9,624.3 around 12:46 pm on Friday. Piramal Enterprises (down 8.14 per cent), Cipla (down 1.75 per cent), Cadila Healthcare (down 1.71 per cent) and Aurobindo Pharma (down 1.18 per cent),were the major laggards in the index. […]

Health Benefits of Fennel Seeds

Health Benefits of Fennel Seeds

Fennel originated in the Mediterranean and has been used in traditional medicine and culinary purposes. It is well known as Foeniculum vulgare and is widely used in mouth fresheners, toothpaste, desserts, antacids and in cuisines. Fennel is an aromatic herb belonging to the Parsley family. The plant grows up to 7 feet tall, bears yellow […]

West Lafayette-Based Endocyte Aquired For $2.1 Billion By Pharma Giant Novartis

West Lafayette-Based Endocyte Aquired For $2.1 Billion By Pharma Giant Novartis

West Lafayette-Based Endocyte Aquired For $2.1 Billion By Pharma Giant Novartis Swiss pharmaceutical giant Novartis says it will acquire West Lafayette-based Endocyte for $2.1 billion. Endocyte was founded in Purdue Research Park and has been working for more than two decades to develop personalized cancer treatments that are more targeted to a specific […]

Sirio Pharma opens new gummy production plant in China

Sirio Pharma opens new gummy production plant in China

China-based dietary supplement manufacturer Sirio Pharma has opened a new gummy production plant in Ma’anshan, China, as it aims to meet increased demand for functional gummies from global markets. The 26,000 square-metre gummy production plant will form part of the company’s 240,000 square-metre ‘Centre of Excellence’, and will increase Sirio’s gummy production capacity to 2.4 […]

Big Pharma, Little Pharma

Big Pharma, Little Pharma

Our attention tends to focus on what the biggest industry players are doing. We conflate size with success and pore over the strategy of firms such as Pfizer, Roche and Sanofi, assuming that we can learn from them and possibly emulate their models. This is understandable but flawed, for at least two reasons. Firstly, it […]

Biotech Analysis Central Pharma News: Regeneron's Results, BMY's Failure, Novartis' FDA Rejection

Biotech Analysis Central Pharma News: Regeneron's Results, BMY's Failure, Novartis' FDA Rejection

Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry. Regeneron And Sanofi Obtain Positive Phase 3 Results With Dupixent News: Recently, Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced that they had obtained positive results from a phase 3 study. The phase 3 […]

FORTUNE and Great Place to Work® Name Horizon Pharma plc to 2018 Best Small & Medium Workplaces for Third …

“We are honored that FORTUNE and Great Place to Work has again named Horizon Pharma as one of its Best Workplaces,” said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma plc. “At Horizon, we take seriously the needs of our employees and work hard to create an environment that fosters career development and growth at […]

Acacia Pharma pitches quick path to refiling Barhemsys

Acacia Pharma pitches quick path to refiling Barhemsys

Brief Dive Brief: Acacia Pharma’s path forward for its experimental drug Barhemsys looks a little clearer, after the Cambridge, U.K.-based company disclosed Monday it anticipates soon being able to resubmit a New Drug Application to the Food and Drug Administration. Acacia’s hopes for Barhemsys were dashed earlier this month when the FDA issued a Complete […]

GW Pharma Pipeline Will Add To Bottom Line And Stock Price

GW Pharma Pipeline Will Add To Bottom Line And Stock Price

Recently, GW Pharma (NASDAQ:GWPH) gained approval for their key epilepsy drug, Epidiolex, by the FDA as a prescription drug; the first cannabis-derived pharmaceutical in America. Epidiolex will be available with a prescription at pharmacies approximately in mid November of this year. The same drug is being tested on various other conditions and the clinical trials […]

Five things for pharma marketers to know: Thursday, October 18, 2018

Five things for pharma marketers to know: Thursday, October 18, 2018

Takeda’s $62 billion acquisition of Shire received Japanese approval. The merger could make Takeda a global top 10 drugmaker if it receives approval from EU antitrust regulators. This decision is to be made by November 6 if further investigation is not needed. (Reuters) Publicis Groupe is planning to sell part of its Publicis Health Service […]